** Straumann STMN.S shares are seen down 2.9% in
pre-market indications after the Swiss dental implant maker gave
2025 margin guidance below expectations
** The company expects the margin on EBIT for the year to
improve by 30 to 60 basis points at constant currency rates
** "The outlook 2025 is ... on margins disappointing,"
Vontobel says
** The broker says as expectations in the stock are high and
Straumann is not overdelivering on results and the outlook, it
expects a negative share price reaction
(Reporting by Bartosz Dabrowski in Gdansk)
((bartosz.dabrowski@thomsonreuters.com;))